Analytical Standards Market Size and Share Analysis by Technique, Application, Methodology - Global Industry Demand Forecast to 2030
시장 개요
세계의 표준 시약 시장 규모는 2023년에 16억 1,890만 달러에 달하며, 2024-2030년에 7.0%의 CAGR로 성장하며, 2030년에는 25억 8,810만 달러에 달할 것으로 예측되고 있습니다. 조사 작업 표준은 재료 및 화학물질이 한층 더 사용되기 위해 넘어야 하는 특정 요건입니다. 이것은 '기준 화합물'이며, 조사 대상물 결정, 미지의 물질 결정, 품질 보증 시험에 필수적입니다.
제약·생명과학 분야에서는 임상시험의 증가에 수반하여 분석용 화학물질의 필요성이 높아지고 있습니다. 이러한 농축 화합물은 예를 들면 의약품의 화학적·물리적 안정성을 분석하기 위해 사용됩니다.
또한 바이오의약품 부문은 세계에서 가장 급성장하고 있는 표준 시약 시장에서 중요한 지위를 차지하고 있습니다. 표준 시약은 어세이 및 각종 바이오마커의 개발부터 랩에서의 제조 및 시험, 미량 물질 식별 및 순도 평가까지 폭넓은 용도가 발견되고 있습니다.
주요 인사이트
2023년, 크로마토그래피 업계 점유율은 25%이며, 예측 기간 중 현저한 발전이 보일 것으로 예측됩니다.
북미 지역은 표준 시약의 일대 시장이며, 예측 기간 중 CAGR은 7.2%입니다.
이 지역은 지방특색 산업, 규제기관에 의한 수출 컴플라이언스, 이 지역에 대한 높은 연구개발 투자로부터 많은 혜택을 받고 있습니다.
세계의 표준 시약 시장을 분석했으며, 시장의 기본 구조·최신 상황 및 주요 촉진·억제요인, 세계 전체 및 지역별·주요 국가 시장 규모의 동향 전망(금액 기반, 2017-2030년), 기술별·용도별·방법별의 상세 동향, 현재의 시장 경쟁 상황, 주요 기업의 개요 등을 조사하여 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 업계의 전망
- 시장 역학
- 동향
- 촉진요인
- 억제요인/과제
- 촉진요인/억제요인의 영향 분석
- 신종 코로나바이러스 감염증(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 세계 시장
- 개요
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 방법별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 방법별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아태평양 시장
제10장 라틴아메리카 시장
제11장 중동 및 아프리카 시장
제12장 미국 시장
- 개요
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 방법별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카공화국 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 참여 기업과 제공 제품/서비스 리스트
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근 전략 개발 상황
제30장 기업 개요
- Merck KGaA
- Agilent Technologies Inc.
- Waters Corporation
- LGC Standards Ltd.
- PerkinElmer Inc.
- SPEX CertiPrep
- AccuStandard Inc.
- Thermo Fisher Scientific Inc.
제31장 부록
KSA
Market Overview
The analytical standards market size stood at USD 1,618.9 million in 2023, and it is expected to grow at a CAGR of 7.0% during 2024-2030, to reach USD 2,588.1 million by 2030. The standards for analytical work are the specific requirements that a material or chemical must exceed to be used further. They are 'reference compounds'; and they are vital in the determination of analytes, determination of unknown substances, and quality assurance testing.
The global market is providing the opportunity to launch products with high commercial viability in pharmaceutical and biotechnology, food safety and quality assurance, environmental analysis, forensics, and many other applications.
The necessity of analytical chemicals is more felt in the pharmaceutical and life sciences sector because of the increasing number of clinical trials. Such concentrated compounds are used to analyze the chemical and physical stability, for instance, of drugs.
As a result, the growing incidence of different diseases that drive drug R&D is projected to bring about a CAGR of 7.3% in the global pharmaceutical and life sciences sector in terms of the forecast period.
Additionally, the biopharmaceutical sector holds the position of the fastest-growing analytical standards marketplace in the world. The analytical standard compounds find a wide range of applications from developing assays and various biomarkers to their production and testing in the labs and the trace material identification and purity assessment.
Key Insights
In 2023, the chromatography category had a substantial industry share of 25% and is projected to witness significant development in the projection period.
Development is propelled by augmented research and development activities in drugs and biopharmaceuticals, along with technical improvements.
Chromatography plays an important role in noticing and separating chemical constituents, monitoring ecologies, studying distant galaxies, advancing medication effectiveness, and characterizing proteins.
The category's improvement is boosted by the increasing populace affected by chronic illnesses, leading to augmented demand for medications.
The North American region is the dominating industry for analytical standards, with an anticipated CAGR of 7.2% during the projection period.
The region benefits a lot from the local industry, export compliance imposed by regulatory authorities, as well as the high R&D investment in the area.
The major makers of reference compounds in North America are the primary source of a large sale of the compounds to the pharmaceutical and chemical industries
The use of analytical technologies is growing in daily life to achieve many purposes in the lab such as environmental monitoring, drug testing, forensic use, food testing, and so on.
The U.S. and Canada, with high per capita incomes and supportive state policies, are experiencing growth in the market by giving people more access to healthcare services.
The contamination of food is a substantial worldwide health concern, leading to food-borne contagions, allergies, and intoxication.
More than 600 million individuals are affected by food-borne diseases yearly, resulting in around 420,000 demises and 33 million healthy life years lost.
Food-borne diseases cause approximately USD 95 billion in productivity loss in low- and middle-income countries, with global treatment costs reaching around USD 15 billion annually.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by technique
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by methodology
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Technique (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.4. Market Revenue, by Methodology (2017-2030)
- 6.5. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Technique (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by Methodology (2017-2030)
- 7.5. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Technique (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by Methodology (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Technique (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by Methodology (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Technique (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by Methodology (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Technique (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by Methodology (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Technique (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by Methodology (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Technique (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by Methodology (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Technique (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by Methodology (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Technique (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by Methodology (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Technique (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by Methodology (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Technique (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by Methodology (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Technique (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by Methodology (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Technique (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by Methodology (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Technique (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by Methodology (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Technique (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by Methodology (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Technique (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by Methodology (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Technique (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by Methodology (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Technique (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by Methodology (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Technique (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by Methodology (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Technique (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by Methodology (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Technique (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by Methodology (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Technique (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by Methodology (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Merck KGaA
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Agilent Technologies Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Waters Corporation
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. LGC Standards Ltd.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. PerkinElmer Inc.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. SPEX CertiPrep
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. AccuStandard Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Thermo Fisher Scientific Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
